InvestorsHub Logo

loanranger

11/02/20 5:01 PM

#331278 RE: TheHound #331264

WAKEFIELD, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today receipt of written feedback from the U.S. Food and Drug Administration (FDA) that is in general agreement with the Company’s planned clinical trial for Brilacidin, a defensin-mimetic drug candidate, for the treatment of COVID-19. The FDA response completes the Pre-Investigational New Drug (Pre-IND) process.

roiresearch

11/02/20 5:06 PM

#331282 RE: TheHound #331264

i think you both have a point about the head scratching phrases used in IPIX prs as it relates to the responses received by the fda, however the more important info is that IPIX today said human trials this Q to commence